Literature DB >> 3544785

Replication of arterial smooth muscle cells in hypertension and atherosclerosis.

D Gordon, S M Schwartz.   

Abstract

Smooth muscle proliferation has been recognized as central to the pathology of both major forms of vascular disease: atherosclerosis and hypertension. Recent advances in our knowledge of the mechanisms of control of proliferation suggest that events occurring in adult animals may recapitulate portions of the developmental biology of the smooth muscle cell. This review will consider the current state of knowledge of the mechanisms controlling smooth muscle proliferation in these 2 diseases, put that knowledge into the context of what is known about smooth muscle biology and offer 2 hypotheses as to possible roles of smooth muscle developmental biology in manifestations of atherosclerosis and hypertension in adult humans.

Entities:  

Mesh:

Year:  1987        PMID: 3544785     DOI: 10.1016/0002-9149(87)90175-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Modulation of response to adenosine in vascular smooth muscle cells cultured in defined medium.

Authors:  Y M Xiong; S Z Xu; L L Slakey
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

2.  Opposite effects of monokines (interleukin-1 and tumor necrosis factor) on proliferation and heparin-binding (fibroblast) growth factor binding to human aortic endothelial and smooth muscle cells.

Authors:  H Sawada; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol       Date:  1990-02

Review 3.  Lipid-lowering drugs.

Authors:  K Pahan
Journal:  Cell Mol Life Sci       Date:  2006-05       Impact factor: 9.261

Review 4.  The good smooth muscle cells in atherosclerosis.

Authors:  S M Schwartz; R Virmani; M E Rosenfeld
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

5.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

Authors:  U C Garg; A Hassid
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

6.  Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.

Authors:  E Buchdunger; J Zimmermann; H Mett; T Meyer; M Müller; U Regenass; N B Lydon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.

Authors:  P Libby; S J Warner; G B Friedman
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

8.  Dual regulation of myocardin expression by tumor necrosis factor-α in vascular smooth muscle cells.

Authors:  Pavneet Singh; Xi-Long Zheng
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 9.  Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP.

Authors:  Sarah A Smith; Andrew C Newby; Mark Bond
Journal:  Cells       Date:  2019-11-16       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.